Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-06-02
Original SEC Filing: Click here

---

Webplus: SVA/20160602/6-K/2_EX-99.1/000.htm SEC Original: v441538_ex99-1.htm
Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase

---

---

Webplus: SVA/20160602/6-K/1/000.htm SEC Original: v441538_6k.htm
FORM 6-K ————– ———- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-06-02CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085